Mama's Creations (MAMA) 10-Q 14 Sep 17 2018 Q2 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	6 Months Ended
	Jul. 31, 2017	Sep. 13, 2017
Document And Entity Information
Entity Registrant Name	MamaMancini's Holdings, Inc.
Entity Central Index Key	1,520,358
Document Type	10-Q
Document Period End Date	Jul. 31, 2017
Amendment Flag	false
Current Fiscal Year End Date	--01-31
Entity Filer Category	Smaller Reporting Company
Entity Common Stock, Shares Outstanding		28,918,433
Trading Symbol	MMMB
Document Fiscal Period Focus	Q2
Document Fiscal Year Focus	2,018

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets - USD ($)	Jul. 31, 2017	Jan. 31, 2017
Assets:
Cash	$ 639,454	$ 666,580
Accounts receivable, net	3,064,576	1,817,820
Inventories	235,207	443,623
Prepaid expenses	143,188	135,747
Due from manufacturer - related party	1,597,518	2,079,708
Total current assets	5,679,943	5,143,478
Property and equipment, net	1,299,183	1,175,508
Deposit on machinery and equipment	493,855
Total Assets	7,472,981	6,318,986
Liabilities:
Accounts payable and accrued expenses	891,609	484,752
Line of credit, net	2,454,151	1,363,145
Term loan	140,004	140,004
Note payable - net	2,126,736	1,401,906
Total current liabilities	5,612,500	3,389,807
Term loan - net of current	443,326	513,328
Note payable - net of current portion		1,298,819
Notes payable - related party	117,656	117,656
Total long-term liabilities	560,982	1,929,803
Total Liabilities	6,173,482	5,319,610
Commitments and contingencies
Stockholders’ Equity:
Preferred stock value
Common stock, $0.00001 par value; 250,000,000 shares authorized; 31,593,665 and 27,810,717 shares issued and outstanding, respectively	315	278
Additional paid in capital	16,064,056	15,825,029
Common stock subscribed, $0.00001 par value; 66,667 shares, respectively	1	1
Accumulated deficit	(14,615,373)	(14,676,432)
Less: Treasury stock, 230,000 shares, respectively	(149,500)	(149,500)
Total Stockholders’ Equity	1,299,499	999,376
Total Liabilities and Stockholders’ Equity	7,472,981	6,318,986
Series A Preferred Stock [Member]
Stockholders’ Equity:
Preferred stock value

Condensed Consolidated Balance3

Condensed Consolidated Balance Sheets (Parenthetical) - $ / shares	Jul. 31, 2017	Jan. 31, 2017
Preferred stock, par value	$ 0.00001	$ 0.00001
Preferred stock, shares authorized	19,880,000	19,880,000
Preferred stock, shares issued
Preferred stock, shares outstanding
Common stock, par value	$ 0.00001	$ 0.00001
Common stock, shares authorized	250,000,000	250,000,000
Common stock, shares issued	31,593,665	27,810,717
Common stock, shares outstanding	31,593,665	27,810,717
Common stock subscribed, par value	$ 0.00001	$ 0.00001
Common stock subscribed, shares	66,667	66,667
Treasury stock, shares	230,000	230,000
Series A Preferred Stock [Member]
Preferred stock, par value	$ 0.00001	$ 0.00001
Preferred stock, shares authorized	120,000	120,000
Preferred stock, shares issued	0	23,400
Preferred stock, shares outstanding	0	23,400

Condensed Consolidated Statemen

Condensed Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended		6 Months Ended
	Jul. 31, 2017	Jul. 31, 2016	Jul. 31, 2017	Jul. 31, 2016
Income Statement [Abstract]
Sales-net of slotting fees and	$ 7,005,434	$ 4,138,280	$ 12,362,735	$ 8,062,257
Costs of Sales	4,995,088	2,772,966	8,452,811	5,221,744
Gross profit	2,010,346	1,365,314	3,909,924	2,840,513
Operating expenses:
Research and development	24,531	37,225	50,119	67,787
General and administrative	1,778,348	1,437,256	3,336,176	2,937,113
Total operating expenses	1,802,879	1,474,481	3,386,295	3,004,900
Income (loss) from operations	207,467	(109,167)	523,629	(164,387)
Other income (expense):
Interest expense	(174,338)	(157,949)	(344,995)	(319,711)
Amortization of debt discount	(8,730)	(9,694)	(26,010)	(18,819)
Total other income (expense)	(183,068)	(167,643)	(371,005)	(338,530)
Net income (loss)	24,399	(276,810)	152,624	(502,917)
Less: preferred dividends	(44,765)	(46,800)	(91,565)	(111,321)
Net (loss) available to common stockholders	$ (20,366)	$ (323,610)	$ 61,059	$ (614,238)
Net loss per common share - basic	$ 0	$ (0.01)	$ 0	$ (0.02)
Net loss per common share - diluted	$ 0	$ (0.01)	$ 0	$ (0.02)
Weighted average common shares outstanding – basic	28,100,066	27,039,199	27,957,789	26,776,279
Weighted average common shares outstanding – diluted	28,100,066	27,039,199	29,799,576	26,776,279

Condensed Consolidated Stateme5

Condensed Consolidated Statements of Changes in Stockholders' Equity (Unaudited) - 6 months ended Jul. 31, 2017 - USD ($)	Series A Preferred Stock [Member]	Common Stock [Member]	Treasury Stock [Member]	Additional Paid In Capital [Member]	Common Stock Subscribed [Member]	Accumulated Deficit [Member]	Total
Balance at Jan. 31, 2017		$ 278	$ (149,500)	$ 15,825,029	$ 1	$ (14,676,432)	$ 999,376
Balance, shares at Jan. 31, 2017	23,400	27,810,717	(230,000)
Common stock issued for services		$ 1		138,499			138,500
Common stock issued for services, shares		135,564
Stock options issued for services				8,999			8,999
Series A Preferred dividend issued in common shares		$ 1		91,564			$ 91,565
Series A Preferred dividend issued in common shares, shares		90,717					90,717
Series A Preferred dividend						(91,565)	$ (91,565)
Conversion of Series A Preferred to common		$ 35		(35)
Conversion of Series A Preferred to common, shares	(23,400)	3,466,667
Net Income						152,624	152,624
Balance at Jul. 31, 2017		$ 315	$ (149,500)	$ 16,064,056	$ 1	$ (14,615,371)	$ 1,299,499
Balance, shares at Jul. 31, 2017		31,503,665	(230,000)

Condensed Consolidated Stateme6

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	6 Months Ended
	Jul. 31, 2017	Jul. 31, 2016
CASH FLOWS FROM OPERATING ACTIVITIES:
Net income (loss)	$ 152,624	$ (502,917)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
Depreciation	219,205	159,703
Amortization of debt discount and debt issuance costs	26,010	18,819
Share-based compensation	147,499	352,137
(Increase) Decrease in:
Accounts receivable	(1,246,756)	116,339
Inventories	208,416	(155,226)
Prepaid expenses	(7,441)	(43,891)
Due from manufacturer - related party	482,190	67,918
Increase (Decrease) in:
Accounts payable and accrued expenses	406,858	(36,285)
Net Cash Provided by (Used In) Operating Activities	388,605	(23,403)
CASH FLOWS FROM INVESTING ACTIVITIES:
Cash paid for fixed assets	(836,735)	(204,083)
Net Cash Used In Investing Activities	(836,735)	(204,083)
CASH FLOWS FROM FINANCING ACTIVITIES:
Repayment of note payable	(600,000)
Borrowings (repayments) of line of credit, net	1,091,006	144,810
Repayment of term loan	(70,002)	(60,000)
Repayment of promissory notes		(180,300)
Net Cash (Used In) Provided By Financing Activities	421,004	(95,490)
Net Decrease in Cash	(27,126)	(322,976)
Cash - Beginning of Period	666,580	587,422
Cash - End of Period	639,454	264,446
SUPPLEMENTARY CASH FLOW INFORMATION:
Income taxes
Interest	145,241	76,311
SUPPLEMENTARY DISCLOSURE OF NON-CASH INVESTING AND FINANCING ACTIVITIES:
Stock issued for Series A Preferred dividends	91,565	178,314
Accrued dividends		64,521
Debt issuance costs included in principal balance of note	52,236
Prepaid stock-based compensation		28,125
Accrued interest reclassified to principal balance of convertible note		$ 270,323

Nature of Operations and Basis

Nature of Operations and Basis of Presentation	6 Months Ended
	Jul. 31, 2017
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Nature of Operations and Basis of Presentation	Note 1 - Nature of Operations and Basis of Presentation Nature of Operations MamaMancini’s Holdings, Inc. (the “Company”), (formerly known as Mascot Properties, Inc.) was organized on July 22, 2009 as a Nevada corporation. The Company has a year-end of January 31. The Company is a manufacturer and distributor of beef meatballs with sauce, turkey meatballs with sauce, beef meat loaf and other similar meats and sauces. The Company’s customers are located throughout the United States, with a large concentration in the Northeast and Southeast. Basis of Presentation The condensed consolidated financial statements and related notes have been prepared in accordance with accounting principles generally accepted in the United States of America (“US GAAP”) and include the accounts of the Company and its wholly-owned subsidiaries. All material intercompany balances and transactions have been eliminated in consolidation. The unaudited financial information furnished herein reflects all adjustments, consisting solely of normal recurring items, which in the opinion of management are necessary to fairly state the financial position of the Company and the results of its operations for the periods presented. This report should be read in conjunction with the Company’s consolidated financial statements and notes thereto included in the Company’s Form 10-K for the year ended January 31, 2017 filed on April 23, 2017. The Company assumes that the users of the interim financial information herein have read or have access to the audited financial statements for the preceding fiscal year and that the adequacy of additional disclosure needed for a fair presentation may be determined in that context. The condensed consolidated balance sheet at January 31, 2017 was derived from audited financial statements but does not include all disclosures required by accounting principles generally accepted in the United States of America. The results of operations for the interim periods presented are not necessarily indicative of results for the year ending January 31, 2018. Going Concern Analysis Going Concern Analysis The Company had a net income (loss) of $152,624 and $(502,917) for the six months ended July 31, 2017 and 2016. In addition, as of July 31, 2017, we had cash and working capital of $639,454 and $67,443, respectively. During the six months ended July 31, 2017, the Company generated cash from operations of $388,605. In addition, the Company was able to negotiate the terms of its note payable with one of the lenders and has exercised an option to extend the maturity date of the note payable to May 1, 2018. Also, continued increases in sales and control of expenses leads management to conclude that it is probable that the Company’s cash resources will be sufficient to meet our cash requirements through the first quarter of fiscal year ended January 31, 2019. If necessary, management also determined that it is probable that external sources of debt and/or equity financing could be obtained based on management’s historical ability to raise capital coupled with current favorable market conditions. As a result of both management’s plans and current trends in improving cash flow, the initial conditions which had raised doubt regarding the entity’s ability to continue as a going concern have been resolved. Therefore, the accompanying condensed consolidated financial statements have been prepared assuming that the Company will continue as a going concern. The condensed consolidated financial statements do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets or the amounts and classification of liabilities that may result from the matters discussed herein. While we believe in the viability of management’s strategy to generate sufficient revenue, control costs and the ability to raise additional funds if necessary, there can be no assurances to that effect. The Company’s ability to continue as a going concern is dependent upon the ability to further implement the business plan, generate sufficient revenues and to control operating expenses.

Summary of Significant Accounti

Summary of Significant Accounting Policies	6 Months Ended
	Jul. 31, 2017
Accounting Policies [Abstract]
Summary of Significant Accounting Policies	Note 2 - Summary of Significant Accounting Policies Use of Estimates The preparation of condensed consolidated financial statements in conformity with U.S. generally accepted accounting principles requires management to make estimates and assumptions that affect the amounts reported in the condensed consolidated financial statements and accompanying notes. Such estimates and assumptions impact, among others, the following: allowance for doubtful accounts, inventory obsolescence and the fair value of share-based payments. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the consolidated financial statements, which management considered in formulating its estimate could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from our estimates. Risks and Uncertainties The Company operates in an industry that is subject to intense competition and change in consumer demand. The Company’s operations are subject to significant risk and uncertainties including financial and operational risks including the potential risk of business failure. The Company has experienced, and in the future expects to continue to experience, variability in sales and earnings. The factors expected to contribute to this variability include, among others, (i) the cyclical nature of the grocery industry, (ii) general economic conditions in the various local markets in which the Company competes, including a potential general downturn in the economy, and (iii) the volatility of prices pertaining to food and beverages in connection with the Company’s distribution of the product. These factors, among others, make it difficult to project the Company’s operating results on a consistent basis. Cash The Company considers all highly liquid instruments purchased with a maturity of three months or less to be cash equivalents. The Company held no cash equivalents at July 31, 2017 or January 31, 2017. The Company minimizes its credit risk associated with cash by periodically evaluating the credit quality of its primary financial institution. The balance at times may exceed federally insured limits. Accounts Receivable and Allowance for Doubtful Accounts Accounts receivable are stated at the amount management expects to collect from outstanding balances. The Company generally does not require collateral to support customer receivables. The Company provides an allowance for doubtful accounts based upon a review of the outstanding accounts receivable, historical collection information and existing economic conditions. The Company determines if receivables are past due based on days outstanding, and amounts are written off when determined to be uncollectible by management. The maximum accounting loss from the credit risk associated with accounts receivable is the amount of the receivable recorded, which is the face amount of the receivable net of the allowance for doubtful accounts. As of July 31, 2017 and January 31, 2017, the Company had reserves of $2,000. Inventories Inventories are stated at average cost using the first-in, first-out (FIFO) valuation method. Inventory was comprised of the following at July 31, 2017 and January 31, 2017: July 31, 2017 January 31, 2017 Finished goods $ 235,207 $ 443,623 Property and Equipment Property and equipment are recorded at cost. Depreciation expense is computed using straight-line methods over the estimated useful lives. Asset lives for financial statement reporting of depreciation are: Machinery and equipment 2-7 years Furniture and fixtures 3 years Leasehold improvements * (*) Amortized on a straight-line basis over the term of the lease or the estimated useful lives, whichever period is shorter. Fair Value of Financial Instruments For purpose of this disclosure, the fair value of a financial instrument is the amount at which the instrument could be exchanged in a current transaction between willing parties, other than in a forced sale or liquidation. The carrying amount of the Company’s short-term financial instruments approximates fair value due to the relatively short period to maturity for these instruments. Stock Issuance Costs Stock issuance costs are capitalized as incurred. Upon the completion of the offering, the stock issuance costs are reclassified to equity and netted against proceeds. In the event the costs are in excess of the proceeds, the costs are recorded to expense. In the case of an aborted offering, all costs are expensed. Research and Development Research and development is expensed as incurred. Research and development expenses for the three months ended July 31, 2017 and 2016 were $24,531 and $37,225, respectively. Research and development expenses for the six months ended July 31, 2017 and 2016 were $50,119 and $67,787, respectively. Shipping and Handling Costs The Company classifies freight billed to customers as sales revenue and the related freight costs as general and administrative expenses. Revenue Recognition The Company records revenue for products when all of the following have occurred: (1) persuasive evidence of an arrangement exists, (2) the product is delivered, (3) the sales price to the customer is fixed or determinable, and (4) collectability of the related customer receivable is reasonably assured. There is no stated right of return for products. The Company meets these criteria upon shipment. Expenses such as slotting fees, sales discounts, and allowances are accounted for as a direct reduction of revenues as follows: Six Months Ended July 31, 2017 Six Months Ended July 31, 2016 Gross Sales $ 12,587,604 $ 8,298,592 Less: Slotting, Discounts, Allowances 224,869 236,335 Net Sales $ 12,362,735 $ 8,062,257 Cost of Sales Cost of sales represents costs directly related to the production and manufacturing of the Company’s products. Costs include product development, freight, packaging, and print production costs. Advertising Costs incurred for producing and communicating advertising for the Company are charged to operations as incurred. Producing and communicating advertising expenses for the three months ended July 31, 2017 and 2016 were $405,349 and $350,665, respectively. Producing and communicating advertising expenses for the six months ended July 31, 2017 and 2016 were $722,943 and $771,557, respectively. Stock-Based Compensation The Company accounts for stock-based compensation in accordance with ASC Topic 718, “ Compensation – Stock Compensation” Equity Based Payments to Non-Employees The Company recognizes all forms of share-based payments, including stock option grants, warrants and restricted stock grants, at their fair value on the grant date, which are based on the estimated number of awards that are ultimately expected to vest. Share-based payments, excluding restricted stock, are valued using a Black-Scholes option pricing model. Grants of share-based payment awards issued to non-employees for services rendered have been recorded at the fair value of the share-based payment, which is the more readily determinable value. The grants are amortized on a straight-line basis over the requisite service periods, which is generally the vesting period. If an award is granted, but vesting does not occur, any previously recognized compensation cost is reversed in the period related to the termination of service. Stock-based compensation expenses are included in cost of goods sold or selling, general and administrative expenses, depending on the nature of the services provided, in the consolidated statement of operations. Share-based payments issued to placement agents are classified as a direct cost of a stock offering and are recorded as a reduction in additional paid in capital. For the three months ended July 31, 2017 and 2016, share-based compensation amounted to $57,349 and $172,929, respectively. For the six months ended July 31, 2017 and 2016, share-based compensation amounted to $147,499 and $352,137, respectively. For the six months ended July 31, 2017 and 2016, when computing fair value of share-based payments, the Company has considered the following variables: July 31, 2017 July 31, 2016 Risk-free interest rate 1.18 % 1.07% to 1.33 % Expected life of grants 3.76 years 2.5 to 3.5 years Expected volatility of underlying stock 298 % 166% to 179 % Dividends 0 % 0 % The expected option term is computed using the “simplified” method as permitted under the provisions of ASC 718-10-S99. The Company uses the simplified method to calculate expected term of share options and similar instruments as the Company does not have sufficient historical exercise data to provide a reasonable basis upon which to estimate expected term. The expected stock price volatility for the Company’s stock options was determined by the historical volatilities for industry peers and used an average of those volatilities. Risk free interest rates were obtained from U.S. Treasury rates for the applicable periods. Earnings (Loss) Per Share Earnings per share (“EPS”) is the amount of earnings attributable to each share of common stock. For convenience, the term is used to refer to either earnings or loss per share. EPS is computed pursuant to Section 260-10-45 of the FASB Accounting Standards Codification. Pursuant to ASC Paragraphs 260-10-45-10 through 260-10-45-16, basic EPS shall be computed by dividing income available to common stockholders (the numerator) by the weighted-average number of common shares outstanding (the denominator) during the period. Income available to common stockholders shall be computed by deducting both the dividends declared in the period on preferred stock (whether or not paid) and the dividends accumulated for the period on cumulative preferred stock (whether or not earned) from income from continuing operations (if that amount appears in the income statement) and also from net income. The computation of diluted EPS is similar to the computation of basic EPS except that the denominator is increased to include the number of additional common shares that would have been outstanding if the dilutive potential common shares had been issued during the period to reflect the potential dilution that could occur from common shares issuable through contingent shares issuance arrangement, stock options or warrants. The following table provides a reconciliation of the numerator and denominator used in computing basic and diluted net income (loss) attributable to common stockholders per common share. For the Three Months Ended July 31, 2017 July 31, 2016 Numerator: Net loss attributable to common stockholders $ (20,366 ) $ (323,610 ) Effect of dilutive securities: — Diluted net (loss) $ (20,366 ) $ (323,610 ) Denominator: Weighted average common shares outstanding - basic 28,100,066 27,039,199 Dilutive securities (a): Series A Preferred - — Options - — Warrants - — Weighted average common shares outstanding and assumed conversion - diluted 28,100,066 27,039,199 Basic net (loss) per common share $ (0.00 ) $ (0.01 ) Diluted net (loss) per common share $ (0.00 ) $ (0.01 ) (a) - Anti-dilutive securities excluded: 7,652,372 9,189,805 For the Six Months Ended July 31, 2017 July 31, 2016 Numerator: Net income/(loss) attributable to common stockholders $ 61,059 $ (614,238 ) Effect of dilutive securities: — Diluted net (loss) $ 61,059 $ (614,238 ) Denominator: Weighted average common shares outstanding - basic 27,957,789 26,776,2798 Dilutive securities (a): Series A Preferred - — Options 254,051 — Warrants 1,587,736 — Weighted average common shares outstanding and assumed conversion - diluted 29,799,576 26,776,279 Basic net (loss) per common share $ (0.00 ) $ (0.02 ) Diluted net (loss) per common share $ (0.00 ) $ (0.02 ) (a) - Anti-dilutive securities excluded: 3,230,150 9,189,805 Income Taxes Income taxes are provided in accordance with ASC No. 740, “ Accounting for Income Taxes Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will not be realized. Deferred tax assets and liabilities are adjusted for the effects of changes in tax laws and rates on the date of enactment. The Company is no longer subject to tax examinations by tax authorities for years prior to 2013. Recent Accounting Pronouncements In July 2015, the FASB issued the ASU No. 2015-11 “ Inventory (Topic 330) Simplifying the Measurement of Inventory” . In April 2016, the FASB issued ASU No. 2016-09, “ Compensation – Stock Compensation (Topic 718) In February 2016, the FASB issued ASU 2016-02, “Leases (Topic 842).” In April 2016, the FASB issued ASU No. 2016-10, “ Revenue from Contracts with Customers: Identifying Performance Obligations and Licensing (Topic 606) Revenue from Contracts with Customers: Principal versus Agent Considerations (Reporting Revenue Gross verses Net) (Topic 606) In May 2016, the FASB issued ASU No. 2016-12, “ Revenue from Contracts with Customers (Topic 606): Narrow-Scope Improvements and Practical Expedients” In August 2016, the FASB issued ASU 2016-15, “Statement of Cash Flows (Topic 230): Classification of Certain Cash Receipts and Cash Payments” In October 2016, the FASB issued ASU 2016-16, “Income Taxes (Topic 740): Intra-Entity Transfers of Assets Other than Inventory”, In November 2016, the FASB issued ASU 2016-18, “Statement of Cash Flows (Topic 230)” Management does not believe that any recently issued, but not yet effective accounting pronouncements, when adopted, will have a material effect on the accompanying consolidated financial statements.

Property and Equipment

Property and Equipment	6 Months Ended
	Jul. 31, 2017
Property, Plant and Equipment [Abstract]
Property and Equipment	Note 3 - Property and Equipment: Property and equipment on July 31, 2017 and January 31, 2017 are as follows: July 31, 2017 January 31, 2017 Machinery and Equipment $ 1,285,187 $ 1,193,473 Furniture and Fixtures 23,067 17,942 Leasehold Improvements 1,071,239 825,198 2,379,493 2,036,613 Less: Accumulated Depreciation 1,080,310 861,105 $ 1,299,183 $ 1,175,508 Depreciation expense charged to income for the three months ended July 31, 2017 and 2016 amounted to $112,124 and $83,000, respectively. Depreciation expense charged to income for the six months ended July 31, 2017 and 2016 amounted to $219,205 and $137,585, respectively.

Investment in Meatball Obsessio

Investment in Meatball Obsession, LLC	6 Months Ended
	Jul. 31, 2017
Investments in and Advances to Affiliates, Schedule of Investments [Abstract]
Investment in Meatball Obsession, LLC	Note 4 - Investment in Meatball Obsession, LLC During 2011, the Company acquired a 34.62% interest in Meatball Obsession, LLC (“MO”) for a total investment of $27,032. This investment is accounted for using the equity method of accounting. Accordingly, investments are recorded at acquisition cost plus the Company’s equity in the undistributed earnings or losses of the entity. At December 31, 2011, the investment was written down to $0 due to losses incurred by MO. The Company’s ownership interest in MO has decreased due to dilution. At July 31, 2017 and January 31, 2017, the Company’s ownership interest in MO was 12% and 12%, respectively.

Related Party Transactions

Related Party Transactions	6 Months Ended
	Jul. 31, 2017
Related Party Transactions [Abstract]
Related Party Transactions	Note 5 - Related Party Transactions Joseph Epstein Foods On March 1, 2010, the Company entered into a five-year agreement with Joseph Epstein Foods (the “Manufacturer”) who is a related party. The Manufacturer is co-owned by the CEO and President of the Company. The Company analyzed the relationship with the Manufacturer to determine if the Manufacturer is a variable interest entity as defined by FASB ASC 810 “ Consolidation” Under the terms of the agreement if the Company specifies any change in packaging or shipping materials which results in the manufacturer incurring increased expense for packaging and shipping materials or in the Manufacturer being unable to utilize obsolete packaging or shipping materials in ordinary packaging or shipping, the Company agrees to pay as additional product cost the additional cost for packaging and shipping materials and to purchase at cost such obsolete packaging and shipping materials. If the Company requests any repackaging of the product, other than due to defects in the original packaging, the Company will reimburse the Manufacturer for any labor costs incurred in repackaging. Per the agreement, all product delivery shipping costs are the expense of the Company. The Company agreed with the Manufacturer at the end of the last fiscal year that Company would purchase a minimum of $965,000 of product each month and that any amount below that sum would be a charge of 12% of that shortfall each month. In return, the Manufacturer obligated itself to offer the Company competitive prices and would not co-pack for other suppliers and would either maintain or lower its payable to the Company each quarter. In addition, the Manufacturer agreed to rebate the Company any overage of gross margin above 12% each month. From time to time the Company will make investments in equipment located at the Manufacturer’s facility. The equipment is capitalized and depreciated by the Company over the estimated useful life. During the three months ended July 31, 2017 and 2016, the Company purchased inventory of $5,062,421 and $2,667,959, respectively, from the Manufacturer. During the six months ended July 31, 2017 and 2016, the Company purchased inventory of $8,369,528 and $5,368,970, respectively, from the Manufacturer. During the three months ended July 31, 2017 and 2016, the Manufacturer incurred expenses of $15,000 and $6,000, respectively, on behalf of the Company for shared administrative expenses and salary expenses. During the six months ended July 31, 2017 and 2016, the Manufacturer incurred expenses of $30,000 and $12,000, respectively, on behalf of the Company for shared administrative expenses and salary expenses. At July 31, 2017 and January 31, 2017, the amount due from the Manufacturer is $1,597,518 and $2,079,708 respectively. Meatball Obsession, LLC A current director of the Company is the chairman of the board and shareholder of Meatball Obsession LLC (“MO”). For the three months ended July 31, 2017 and 2016, the Company generated approximately $10,468 and $223 in revenues from MO, respectively. For the six months ended July 31, 2017 and 2016, the Company generated approximately $33,039 and $10,325 in revenues from MO, respectively. As of July 31, 2017 and January 31, 2017, the Company had a receivable of $5,261 and $8,189 due from MO, respectively. WWS, Inc. A current director of the Company is the president of WWS, Inc. For the three months ended July 31, 2017 and 2016, the Company recorded $12,000 and $12,000 in commission expense from WWS, Inc. generated sales, respectively. For the six months ended July 31, 2017 and 2016, the Company recorded $24,000 and $24,000 in commission expense from WWS, Inc. generated sales, respectively. Notes Payable – Related Party During the year ended January 31, 2016, the Company received aggregate proceeds of $125,000 from notes payable with the CEO of the Company. The notes bear interest at a rate of 4% per annum and matured on December 31, 2016. The notes were subsequently extended until February 2019. As of July 31, 2017 and January 31, 2017, the outstanding principal balance of the notes was $117,656.

Loan and Security Agreement

Loan and Security Agreement	6 Months Ended
	Jul. 31, 2017
Debt Disclosure [Abstract]
Loan and Security Agreement	Note 6 - Loan and Security Agreement On September 3, 2014, the Company entered into a Loan and Security Agreement (“Loan and Security Agreement”) with Entrepreneur Growth Capital, LLC (“EGC”) which contains a line of credit. As of July 31, 2017 and January 31, 2017, the outstanding balance on the line of credit was $2,454,151 and $1,363,145, respectively. In September 2016, the agreement was amended and the total facility increased to an aggregate principal amount of up to $3,200,000. The facility consists of the following: ● Accounts Revolving Line of Credit: $ 2,150,000 ● Inventory Revolving Line of Credit: $ 350,000 ● Term Loan: $ 700,000 EGC may from time to time make loans in an aggregate amount not to exceed the Accounts Revolving Line of Credit up to 85% of the net amount of Eligible Accounts (as defined in the Loan and Security Agreement). In July 2017, EGC made an accommodation whereby the Accounts Receivable Line of Credit could be increased to $2,500,000, provided that the aggregate principal amount of the facility did not exceed $3,200,000. Also, in July 2017, EGC advanced an additional loan to the Company in the principal amount of $300,000, subject to $50,000 monthly repayments commencing July 31, 2017. EGC may from time to time make loans in an aggregate amount not to exceed the Inventory Revolving Line of Credit against Eligible Inventory (as defined in the Loan and Security Agreement) in an amount up to 50% of finished goods and in an amount up to 20% of raw material, which is capped at $30,000. The revolving interest rates is equal to the highest prime rate in effect during each month as generally reported by Citibank, N.A. plus (a) 2.5% on loans and advances made against eligible accounts and (b) 4.0% on loans made against eligible inventory. The term loan bears interest at a rate of the highest prime rate in effect during each month as generally reported by Citibank, N.A. plus 4.0%. The initial term of the facility is for a period of two years and will automatically renew for an additional one-year period. The Company is required to pay an annual facility fee equal to 0.75% of the total $3,200,000 facility and pays an annualized maintenance fee equal to 2.16% of the total facility. In the event of default, the Company shall pay 10% above the stated rates of interest per the Agreement. The drawdowns are secured by all of the assets of the Company. Due to the terms of the agreement regarding a subjective acceleration clause and a lockbox arrangement, the line of credit is shown as a current liability on the condensed consolidated balance sheets. On September 3, 2014, the Company also entered into a 5 year $600,000 Secured Promissory Note (“EGC Note”) with EGC. In September 2016, the ECG Note was increased to $700,000 with an extended maturity date of September 30, 2021. The amended EGC Note is payable in 60 monthly installments of $11,667. The EGC Note bears interest at the prime rate plus 4.0% and is payable monthly, in arrears. In the event of default, the Company shall pay 10% above the stated rates of interest per the Loan and Security Agreement. The EGC Note is secured by all of the assets of the Company. The outstanding balance on the term loan was $583,330 and $653,332 as of July 31, 2017 and January 31, 2017, respectively. Additionally, in connection with the Loan and Security Agreement, Carl Wolf, the Company’s Chief Executive Officer, entered into a Guarantee Agreement with EGC, personally guaranteeing all the amounts borrowed on behalf of the Company under the Loan and Security Agreement.

Note Payable

Note Payable	6 Months Ended
	Jul. 31, 2017
Debt Disclosure [Abstract]
Note Payable	Note 7 –Note Payable On December 19, 2014, the Company entered into a securities purchase agreement (the “Manatuck Purchase Agreement”) with Manatuck Hill Partners, LLC (“Manatuck”) whereby the Company issued a convertible redeemable debenture (the “Manatuck Debenture”) in favor of Manatuck. The Manatuck Debenture is for $2,000,000 bearing interest at a rate of 14% and matures in February 2016. Upon issuance of the Manatuck Debenture, the Company granted Manatuck 200,000 shares of the Company’s restricted common stock. In April 2015, the maturity date was extended to May 2016 and 30,000 shares of restricted common stock were issued to Manatuck. Based on management’s review, the accounting for debt modification applied. The Company valued the 30,000 shares at the grant date share price of $1.32 and recorded $39,600 to debt discount on the consolidated balance sheet. Upon issuance of the debenture and subsequent extension, a debt discount of $498,350 was recorded for the fees incurred by the buyer as well as the value of the common shares granted to Manatuck. The debt discount will be amortized over the earlier of (i) the term of the debt or (ii) conversion of the debt, using the straight-line method which approximates the effective interest method. The amortization of debt discount is included as a component of other expense in the consolidated statements of operations. On October 29, 2015, the note was further amended to extend the maturity date to December 19, 2016. Per the terms of the execution of the extension, the Company was required to purchase the above 230,000 shares issued to Manatuck for a share price of $0.65, a value of $149,500 and incurred an amendment fee of $170,500, both of which were added to the outstanding principal of the debt. In addition, the extension reduced accrued interest by $220,000 and increased the outstanding principal of the debt by $220,000. Based on management’s review, the accounting for debt extinguishment applied. In accordance with the accounting for debt extinguishment, the Company wrote-off the existing debt of $2,000,000, wrote-off the unamortized debt discount of $190,483 and wrote-off the remaining debt issuance costs relating to this note of $19,106. The loss on debt extinguishment of $380,089 on the statement of operations is comprised of the write-off of the remaining debt discount of $190,483, the write-off of the debt issuance costs of $19,106, and the amendment fee of $170,500. In August 2016, the note was further amended to extend the maturity date to September 30, 2017 and also removed the convertible feature of the note. The principal amount of the note was increased to $2,898,523, which is inclusive of accrued interest payable through October 31, 2016. In addition, the Company paid an origination fee of $50,000 on October 31, 2016 which is recorded as a debt discount and will be amortized over the remaining life of the note using the effective interest method. On March 10, 2017, the Company further extended the maturity date to May 1, 2018. Per the terms of the amended agreement: 1) The Company will pay to Manatuck a cash fee equal to two percent (2%) of the mutually-agreed pro-forma balance payable on account of the note as of March 31, 2017, which shall include all interest which would be accrued on the note through March 31, 2017; 2) The Company shall make monthly principal payments to Manatuck as follows: March 2017-September 2017 $ 100,000 October 2017-December 2017 $ 150,000 January 2018-May 1, 2018 $ 200,000 Based on management’s review of the amended agreement and extension, the accounting for debt modification applied. The Company accrued the 2% fee totaling $52,236 which is recorded as a debt discount and will be amortized over the remaining life of the note using the effective interest method. There was unamortized debt discount of $74,320 and $48,094 as of July 31, 2017 and January 31, 2017, respectively. The outstanding balance including principal and interest and net of debt discount at July 31, 2017 and January 31, 2017 was $2,126,736 and $2,700,725, respectively. Future maturities of all debt (including debt discussed above in Notes 5, 6 and 7) are as follows: For the Twelve-Month Period Ending July 31, 2018 $ 4,720,891 2019 257,660 2020 140,004 2021 140,004 2022 23,314 $ 5,281,873

Concentrations

Concentrations	6 Months Ended
	Jul. 31, 2017
Risks and Uncertainties [Abstract]
Concentrations	Note 8 - Concentrations Revenues During the six months ended July 31, 2017, the Company earned revenues from three customers representing approximately 39%, 11% and 10% of gross sales. During the six months ended July 31, 2016, the Company earned revenues from four customers representing approximately 20%, 13%, 12% and 11% of gross sales. As of July 31, 2017, these three customers represented approximately 43%, 11% and 19% of total gross outstanding receivables, respectively. As of July 31, 2016, these four customers represented approximately 19%, 17%, and 12% of total gross outstanding receivables, respectively. Cost of Sales For the six months ended July 31, 2017 and 2016, one vendor (Joseph Epstein Foods, Inc.—a related party) represented approximately 100% and 100% of the Company’s purchases, respectively.

Stockholders' Equity

Stockholders' Equity	6 Months Ended
	Jul. 31, 2017
Equity [Abstract]
Stockholders' Equity	Note 9 - Stockholders’ Equity Common Stock On July 27, 2017 (after the effective date), 23,400 shares of the Company’s Series A Preferred Stock were automatically converted into approximately 3,466,667 shares of the Company’s Common Stock. Pursuant to the terms of the Certificate of Designation, a triggering event for the automatic conversion of the Series A Preferred Stock occurred on June 27, 2017 when the volume weighted average price of the Common Stock during a ten consecutive trading day period was at least $1.0125. The conversion became effective on July 27, 2017. During the six months ended July 31, 2017, the Company issued 90,717 shares of its common stock to the holders of the Series A preferred Stock for dividends in arrears totaling $91,565. During the six months ended July 31, 2017, the Company issued 135,564 shares of its common stock to employees and consultants for services rendered of $138,500. Treasury Stock As discussed in Note 7, upon amendment of the Manatuck Debenture on October 29, 2015, the Company repurchased the 230,000 shares for an aggregate purchase price of $149,500 which is presented as Treasury Stock on the condensed consolidated balance sheets. (C) Options The following is a summary of the Company’s option activity: Options Weighted Average Exercise Price Outstanding – January 31, 2017 881,404 $ 0.78 Exercisable – January 31, 2017 799,404 $ 0.78 Granted - $ - Exercised - $ - Forfeited/Cancelled (229,404 ) $ 1.00 Outstanding – July 31, 2017 652,000 $ 0.71 Exercisable – July 31, 2017 611,000 $ 0.71 Options Outstanding Options Exercisable Exercise Price Number Outstanding Weighted Average Remaining Contractual Life (in years) Weighted Average Exercise Price Number Exercisable Weighted Average Exercise Price $ 0.39 – 2.97 652,000 2.51 years $ 0.71 611,000 $ 0.71 At July 31, 2017 the total intrinsic value of options outstanding and exercisable was $323,560 and $299,780, respectively. For the six months ended July 31, 2017 and 2016, the Company recognized share-based compensation related to options of an aggregate of $8,999 and $112,304, respectively. At July 31, 2017, unrecognized share-based compensation was $23,405. (D) Warrants The following is a summary of the Company’s warrant activity: Warrants Weighted Average Exercise Price Outstanding – January 31, 2017 7,311,770 $ 1.04 Exercisable – January 31, 2017 7,311,770 $ 1.04 Granted - $ - Exercised - $ - Forfeited/Cancelled (311,400 ) $ 1.00 Outstanding – July 31, 2017 7,000,372 $ 1.05 Exercisable – July 31, 2017 7,000,372 $ 1.05 Warrants Outstanding Warrants Exercisable Range of Exercise Price Number Outstanding Weighted Average Remaining Contractual Life (in years) Weighted Average Exercise Price Number Exercisable Weighted Average Exercise Price $ 0.68-$2.50 7,000,372 3.06 years $ 1.05 7,000,372 $ 1.05 At July 31, 2017, the total intrinsic value of warrants outstanding and exercisable was $1,873,529 and $1,873,529, respectively.

Commitments and Contingencies

Commitments and Contingencies	6 Months Ended
	Jul. 31, 2017
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Note 10 - Commitments and Contingencies Litigations, Claims and Assessments From time to time, the Company may become involved in various lawsuits and legal proceedings, which arise in the ordinary course of business. Litigation is subject to inherent uncertainties, and an adverse result in these or other matters may arise from time to time that may harm its business. The Company is currently not aware of any such legal proceedings or claims that they believe will have, individually or in the aggregate, a material adverse effect on its business, financial condition or operating results. Licensing and Royalty Agreements On March 1, 2010, the Company was assigned a Development and License agreement (the “Agreement”). Under the terms of the Agreement the Licensor shall develop for the Company a line of beef meatballs with sauce, turkey meatballs with sauce and other similar meats and sauces for commercial manufacture, distribution and sale (each a “Licensor Product” and collectively the “Licensor Products”). Licensor shall work with Licensee to develop Licensor Products that are acceptable to Licensee. Upon acceptance of a Licensor Product by Licensee, Licensor’s trade secret recipes, formulas methods and ingredients for the preparation and production of such Licensor Products (the “Recipes”) shall be subject to this Development and License Agreement. The term of the Agreement (the “Term”) shall consist of the Exclusive Term and the Non-Exclusive Term. The 12-month period beginning on each January 1 and ending on each December 31 is referred to herein as an “Agreement Year”. The Exclusive Term began on January 1, 2009 (the “Effective Date”) and ends on the 50th anniversary of the Effective Date, unless terminated or extended as provided herein. Licensor, at its option, may terminate the Exclusive Term by notice in writing to Licensee, delivered between the 60th and the 90th day following the end of any Agreement Year if, on or before the 60th day following the end of such Agreement Year, Licensee has not paid Licensor Royalties with respect to such Agreement Year at least equal to the minimum royalty (the “Minimum Royalty”) for such Agreement Year. Subject to the foregoing sentence, and provided Licensee has not breached this Agreement and failed to cure such breach in accordance herewith, Licensee may extend the Exclusive Term for an additional twenty-five (25) years, by notice in writing to Licensor, delivered on or before the 50th anniversary of the Effective Date. The Non-Exclusive Term begins upon expiration of the Exclusive Term and continues indefinitely thereafter, until terminated by Licensor due to a material breach hereof by Licensee that remains uncured after notice and opportunity to cure in accordance herewith, or until terminated by Licensee. Either party may terminate this Agreement in the event that the other party materially breaches its obligations and fails to cure such material breach within sixty (60) days following written notice from the non-breaching party specifying the nature of the breach. The following termination rights are in addition to the termination rights provided elsewhere in the agreement. ● Termination by Licensee - Licensee shall have the right to terminate this Agreement at any time on sixty (60) days written notice to Licensor. In such event, all moneys paid to Licensor shall be deemed non-refundable. Under the terms of the Agreement the Company is required to pay quarterly royalty fees as follows: During the Exclusive Term and the Non-Exclusive Term the Company will pay a royalty equal to the royalty rate (the “Royalty Rate”), multiplied by Company’s “Net Sales”. As used herein, “Net Sales” means gross invoiced sales of Products, directly or indirectly to unrelated third parties, less (a) discounts (including cash discounts), and retroactive price reductions or allowances actually allowed or granted from the billed amount (collectively “Discounts”); (b) credits, rebates, and allowances actually granted upon claims, rejections or returns, including recalls (voluntary or otherwise) (collectively, “Credits”); (c) freight, postage, shipping and insurance charges; (d) taxes, duties or other governmental charges levied on or measured by the billing amount, when included in billing, as adjusted for rebates and refunds; and (e) provisions for uncollectible accounts determined in accordance with reasonable accounting methods, consistently applied. The Royalty Rate shall be: 6% of net sales up to $500,000 of net sales for each Agreement year; 4% of Net Sales from $500,000 up to $2,500,000 of Net Sales for each Agreement year; 2% of Net Sales from $2,500,000 up to $20,000,000 of Net Sales for each Agreement year; and 1% of Net Sales in excess of $20,000,000 of Net Sales for each Agreement year. In order to continue the Exclusive term, the Company shall pay a minimum royalty with respect to the preceding Agreement year as follows: Agreement Year Minimum Royalty to be Paid with Respect to Such Agreement Year 1 st nd $ - 3 rd th $ 50,000 5 th th $ 75,000 8 th th $ 100,000 10 th $ 125,000 The Company incurred $89,244 and $55,980 of royalty expenses for the three months ended July 31, 2017 and 2016. Royalty expenses are included in general and administrative expenses on the consolidated statement of operations. The Company incurred $206,191 and $141,684 of royalty expenses for the six months ended July 31, 2017 and 2016. Royalty expenses are included in general and administrative expenses on the consolidated statement of operations. Agreements with Placement Agents and Finders (A) April 1, 2015 The Company entered into a fourth Financial Advisory and Investment Banking Agreement with Spartan Capital Securities, LLC (“Spartan”) effective April 1, 2015 (the “Spartan Advisory Agreement”). Pursuant to the Spartan Advisory Agreement, the Company shall pay to Spartan a non-refundable monthly fee of $10,000 through October 1, 2015. The monthly fee shall survive any termination of the Agreement. Additionally, (i) if at least $4,000,000 is raised in the Financing, the Company shall pay to Spartan a non-refundable fee of $5,000 per month from November 1, 2015 through October 2017; and (ii) if at least $5,000,000 is raised in the Financing, the Company shall pay to Spartan a non-refundable fee of $5,000 per month from November 1, 2017 through October 2019. If $10,000,000 or more is raised in the Financing, the Company shall issue to Spartan shares of its common stock having an aggregate value of $5,000 (as determined by reference to the average volume weighted average trading price for the last five trading days of the immediately preceding month) on the first day of each month during the period from November 1, 2015 through October 1, 2019. The Company upon closing of the Financing shall pay consideration to Spartan, in cash, a fee in an amount equal to 10% of the aggregate gross proceeds raised in the Financing and 3% of the aggregate gross proceeds raised in the Financing for expenses incurred by Spartan. The Company shall grant and deliver to Spartan at the closing of the Financing, for nominal consideration, five-year warrants to purchase a number of shares of the Company’s common stock equal to 10% of the number of shares of common stock (and/or shares of common stock issuable upon exercise of securities or upon conversion or exchange of convertible or exchangeable securities) sold at such closing. The warrants shall be exercisable at any time during the five-year period commencing on the closing to which they relate at an exercise price equal to the purchase price per share of common stock paid by investors in the Financing or, in the case of exercisable, convertible, or exchangeable securities, the exercise, conversion or exchange price thereof. If the Financing is consummated by means of more than one closing, Spartan shall be entitled to the fees provided herein with respect to each such closing. During the year ended January 31, 2016, the Company paid to Spartan a one-time engagement fee of $10,000. In connection with the Initial Closing, the Company agreed to pay an aggregate cash fee and non-accountable allowance of $157,300. The Company also granted warrants to purchase 179,259 shares of common stock at $0.675 per share. The warrants have a grant date fair value of $84,547 which is treated as a direct cost of the Financing and has been recorded as a reduction in additional paid in capital. During the six months ended July 31, 2017, no payments were made to Spartan. Operating Lease In January 2015, the Company began a lease agreement for office space in East Rutherford, NJ. The lease is for a 51-month term expiring on March 31, 2019 with annual payments of $18,847. Total future minimum payments required under operating lease as of July 31, 2017 are as follows: For the Twelve Months Ending July 31, 2018 $ 18,852 2019 12,568 $ 31,420

Subsequent Events

Subsequent Events	6 Months Ended
	Jul. 31, 2017
Subsequent Events [Abstract]
Subsequent Events	Note 11 – Subsequent Events The Company has evaluated subsequent events through the date the financial statements were available to be issued. Based on this evaluation, the Company has identified the following reportable subsequent events other than those disclosed elsewhere in these financials. Proposed Merger with Joseph Epstein Food Enterprises, Inc. (“JEFE”) Following extensive discussion and due diligence (including a third party valuation of JEFE commissioned by the Company’s Board of Directors), on September 7, 2017, the Company and JEFE executed a Letter of Intent pursuant to which the parties have agreed in principle that, pursuant to the terms detailed in the Letter of Intent and subject to certain additional terms and conditions and the execution of a definitive Merger Agreement and related agreements and documents, JEFE will merge with and into the Company (or a wholly-owned subsidiary thereof). In connection with the merger, the Company will acquire all assets of JEFE which were estimated to be approximately $2,928,825 as of July 31, 2017. The consideration for the transaction will be (a) the extinguishment of the Inter-Company Loan between the parties which was $1,597,518 at July 31, 2017, (b) the assumption by the Company of all JEFE accounts payable and accrued expenses which are estimated to be $2,656,948 at July 31, 2017, (c) assumption by the Company of certain third-party loans to JEFE totaling approximately $782,000 and (d) indemnification of Carl Wolf with respect to his collateralization of a bank loan to JEFE in the amount of approximately $250,000. As a result of the transaction, (i) the Company will become the sole shareholder of JEFE either directly or through a wholly-owned subsidiary and (ii) following the closing, JEFE will be a wholly-owned subsidiary of the Company and its financial statements as of the Closing shall be consolidated with the Consolidated Financial Statements of the Company (collectively, the “Merger Transaction”). No cash will be exchanged in this transaction. The estimated assets of JEFE and consideration to be paid in connection with the merger transaction are subject to final due diligence by the Company and the audit of JEFE’s financial statements. The parties intend to close the Merger Transaction on or about November 1, 2017.

Summary of Significant Accoun18

Summary of Significant Accounting Policies (Policies)	6 Months Ended
	Jul. 31, 2017
Accounting Policies [Abstract]
Use of Estimates	Use of Estimates The preparation of condensed consolidated financial statements in conformity with U.S. generally accepted accounting principles requires management to make estimates and assumptions that affect the amounts reported in the condensed consolidated financial statements and accompanying notes. Such estimates and assumptions impact, among others, the following: allowance for doubtful accounts, inventory obsolescence and the fair value of share-based payments. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the consolidated financial statements, which management considered in formulating its estimate could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from our estimates.
Risks and Uncertainties	Risks and Uncertainties The Company operates in an industry that is subject to intense competition and change in consumer demand. The Company’s operations are subject to significant risk and uncertainties including financial and operational risks including the potential risk of business failure. The Company has experienced, and in the future expects to continue to experience, variability in sales and earnings. The factors expected to contribute to this variability include, among others, (i) the cyclical nature of the grocery industry, (ii) general economic conditions in the various local markets in which the Company competes, including a potential general downturn in the economy, and (iii) the volatility of prices pertaining to food and beverages in connection with the Company’s distribution of the product. These factors, among others, make it difficult to project the Company’s operating results on a consistent basis.
Cash	Cash The Company considers all highly liquid instruments purchased with a maturity of three months or less to be cash equivalents. The Company held no cash equivalents at July 31, 2017 or January 31, 2017. The Company minimizes its credit risk associated with cash by periodically evaluating the credit quality of its primary financial institution. The balance at times may exceed federally insured limits.
Accounts Receivable and Allowance for Doubtful Accounts	Accounts Receivable and Allowance for Doubtful Accounts Accounts receivable are stated at the amount management expects to collect from outstanding balances. The Company generally does not require collateral to support customer receivables. The Company provides an allowance for doubtful accounts based upon a review of the outstanding accounts receivable, historical collection information and existing economic conditions. The Company determines if receivables are past due based on days outstanding, and amounts are written off when determined to be uncollectible by management. The maximum accounting loss from the credit risk associated with accounts receivable is the amount of the receivable recorded, which is the face amount of the receivable net of the allowance for doubtful accounts. As of July 31, 2017 and January 31, 2017, the Company had reserves of $2,000.
Inventories	Inventories Inventories are stated at average cost using the first-in, first-out (FIFO) valuation method. Inventory was comprised of the following at July 31, 2017 and January 31, 2017: July 31, 2017 January 31, 2017 Finished goods $ 235,207 $ 443,623
Property and Equipment	Property and Equipment Property and equipment are recorded at cost. Depreciation expense is computed using straight-line methods over the estimated useful lives. Asset lives for financial statement reporting of depreciation are: Machinery and equipment 2-7 years Furniture and fixtures 3 years Leasehold improvements * (*) Amortized on a straight-line basis over the term of the lease or the estimated useful lives, whichever period is shorter.
Fair Value of Financial Instruments	Fair Value of Financial Instruments For purpose of this disclosure, the fair value of a financial instrument is the amount at which the instrument could be exchanged in a current transaction between willing parties, other than in a forced sale or liquidation. The carrying amount of the Company’s short-term financial instruments approximates fair value due to the relatively short period to maturity for these instruments.
Stock Issuance Costs	Stock Issuance Costs Stock issuance costs are capitalized as incurred. Upon the completion of the offering, the stock issuance costs are reclassified to equity and netted against proceeds. In the event the costs are in excess of the proceeds, the costs are recorded to expense. In the case of an aborted offering, all costs are expensed.
Research and Development	Research and Development Research and development is expensed as incurred. Research and development expenses for the three months ended July 31, 2017 and 2016 were $24,531 and $37,225, respectively. Research and development expenses for the six months ended July 31, 2017 and 2016 were $50,119 and $67,787, respectively.
Shipping and Handling Costs	Shipping and Handling Costs The Company classifies freight billed to customers as sales revenue and the related freight costs as general and administrative expenses.
Revenue Recognition	Revenue Recognition The Company records revenue for products when all of the following have occurred: (1) persuasive evidence of an arrangement exists, (2) the product is delivered, (3) the sales price to the customer is fixed or determinable, and (4) collectability of the related customer receivable is reasonably assured. There is no stated right of return for products. The Company meets these criteria upon shipment. Expenses such as slotting fees, sales discounts, and allowances are accounted for as a direct reduction of revenues as follows: Six Months Ended July 31, 2017 Six Months Ended July 31, 2016 Gross Sales $ 12,587,604 $ 8,298,592 Less: Slotting, Discounts, Allowances 224,869 236,335 Net Sales $ 12,362,735 $ 8,062,257
Cost of Sales	Cost of Sales Cost of sales represents costs directly related to the production and manufacturing of the Company’s products. Costs include product development, freight, packaging, and print production costs.
Advertising	Advertising Costs incurred for producing and communicating advertising for the Company are charged to operations as incurred. Producing and communicating advertising expenses for the three months ended July 31, 2017 and 2016 were $405,349 and $350,665, respectively. Producing and communicating advertising expenses for the six months ended July 31, 2017 and 2016 were $722,943 and $771,557, respectively.
Stock-Based Compensation	Stock-Based Compensation The Company accounts for stock-based compensation in accordance with ASC Topic 718, “ Compensation – Stock Compensation” Equity Based Payments to Non-Employees The Company recognizes all forms of share-based payments, including stock option grants, warrants and restricted stock grants, at their fair value on the grant date, which are based on the estimated number of awards that are ultimately expected to vest. Share-based payments, excluding restricted stock, are valued using a Black-Scholes option pricing model. Grants of share-based payment awards issued to non-employees for services rendered have been recorded at the fair value of the share-based payment, which is the more readily determinable value. The grants are amortized on a straight-line basis over the requisite service periods, which is generally the vesting period. If an award is granted, but vesting does not occur, any previously recognized compensation cost is reversed in the period related to the termination of service. Stock-based compensation expenses are included in cost of goods sold or selling, general and administrative expenses, depending on the nature of the services provided, in the consolidated statement of operations. Share-based payments issued to placement agents are classified as a direct cost of a stock offering and are recorded as a reduction in additional paid in capital. For the three months ended July 31, 2017 and 2016, share-based compensation amounted to $57,349 and $172,929, respectively. For the six months ended July 31, 2017 and 2016, share-based compensation amounted to $147,499 and $352,137, respectively. For the six months ended July 31, 2017 and 2016, when computing fair value of share-based payments, the Company has considered the following variables: July 31, 2017 July 31, 2016 Risk-free interest rate 1.18 % 1.07% to 1.33 % Expected life of grants 3.76 years 2.5 to 3.5 years Expected volatility of underlying stock 298 % 166% to 179 % Dividends 0 % 0 % The expected option term is computed using the “simplified” method as permitted under the provisions of ASC 718-10-S99. The Company uses the simplified method to calculate expected term of share options and similar instruments as the Company does not have sufficient historical exercise data to provide a reasonable basis upon which to estimate expected term. The expected stock price volatility for the Company’s stock options was determined by the historical volatilities for industry peers and used an average of those volatilities. Risk free interest rates were obtained from U.S. Treasury rates for the applicable periods.
Earnings (Loss) Per Share	Earnings (Loss) Per Share Earnings per share (“EPS”) is the amount of earnings attributable to each share of common stock. For convenience, the term is used to refer to either earnings or loss per share. EPS is computed pursuant to Section 260-10-45 of the FASB Accounting Standards Codification. Pursuant to ASC Paragraphs 260-10-45-10 through 260-10-45-16, basic EPS shall be computed by dividing income available to common stockholders (the numerator) by the weighted-average number of common shares outstanding (the denominator) during the period. Income available to common stockholders shall be computed by deducting both the dividends declared in the period on preferred stock (whether or not paid) and the dividends accumulated for the period on cumulative preferred stock (whether or not earned) from income from continuing operations (if that amount appears in the income statement) and also from net income. The computation of diluted EPS is similar to the computation of basic EPS except that the denominator is increased to include the number of additional common shares that would have been outstanding if the dilutive potential common shares had been issued during the period to reflect the potential dilution that could occur from common shares issuable through contingent shares issuance arrangement, stock options or warrants. The following table provides a reconciliation of the numerator and denominator used in computing basic and diluted net income (loss) attributable to common stockholders per common share. For the Three Months Ended July 31, 2017 July 31, 2016 Numerator: Net loss attributable to common stockholders $ (20,366 ) $ (323,610 ) Effect of dilutive securities: — Diluted net (loss) $ (20,366 ) $ (323,610 ) Denominator: Weighted average common shares outstanding - basic 28,100,066 27,039,199 Dilutive securities (a): Series A Preferred - — Options - — Warrants - — Weighted average common shares outstanding and assumed conversion - diluted 28,100,066 27,039,199 Basic net (loss) per common share $ (0.00 ) $ (0.01 ) Diluted net (loss) per common share $ (0.00 ) $ (0.01 ) (a) - Anti-dilutive securities excluded: 7,652,372 9,189,805 For the Six Months Ended July 31, 2017 July 31, 2016 Numerator: Net income/(loss) attributable to common stockholders $ 61,059 $ (614,238 ) Effect of dilutive securities: — Diluted net (loss) $ 61,059 $ (614,238 ) Denominator: Weighted average common shares outstanding - basic 27,957,789 26,776,2798 Dilutive securities (a): Series A Preferred - — Options 254,051 — Warrants 1,587,736 — Weighted average common shares outstanding and assumed conversion - diluted 29,799,576 26,776,279 Basic net (loss) per common share $ (0.00 ) $ (0.02 ) Diluted net (loss) per common share $ (0.00 ) $ (0.02 ) (a) - Anti-dilutive securities excluded: 3,230,150 9,189,805
Income Taxes	Income Taxes Income taxes are provided in accordance with ASC No. 740, “ Accounting for Income Taxes Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will not be realized. Deferred tax assets and liabilities are adjusted for the effects of changes in tax laws and rates on the date of enactment. The Company is no longer subject to tax examinations by tax authorities for years prior to 2013.
Recent Accounting Pronouncements	Recent Accounting Pronouncements In July 2015, the FASB issued the ASU No. 2015-11 “ Inventory (Topic 330) Simplifying the Measurement of Inventory” . In April 2016, the FASB issued ASU No. 2016-09, “ Compensation – Stock Compensation (Topic 718) In February 2016, the FASB issued ASU 2016-02, “Leases (Topic 842).” In April 2016, the FASB issued ASU No. 2016-10, “ Revenue from Contracts with Customers: Identifying Performance Obligations and Licensing (Topic 606) Revenue from Contracts with Customers: Principal versus Agent Considerations (Reporting Revenue Gross verses Net) (Topic 606) In May 2016, the FASB issued ASU No. 2016-12, “ Revenue from Contracts with Customers (Topic 606): Narrow-Scope Improvements and Practical Expedients” In August 2016, the FASB issued ASU 2016-15, “Statement of Cash Flows (Topic 230): Classification of Certain Cash Receipts and Cash Payments” In October 2016, the FASB issued ASU 2016-16, “Income Taxes (Topic 740): Intra-Entity Transfers of Assets Other than Inventory”, In November 2016, the FASB issued ASU 2016-18, “Statement of Cash Flows (Topic 230)” Management does not believe that any recently issued, but not yet effective accounting pronouncements, when adopted, will have a material effect on the accompanying consolidated financial statements.

Summary of Significant Accoun19

Summary of Significant Accounting Policies (Tables)	6 Months Ended
	Jul. 31, 2017
Accounting Policies [Abstract]
Schedule of Inventories	Inventories are stated at average cost using the first-in, first-out (FIFO) valuation method. Inventory was comprised of the following at July 31, 2017 and January 31, 2017: July 31, 2017 January 31, 2017 Finished goods $ 235,207 $ 443,623
Schedule of Property and Equipment Estimated Useful Lives	Asset lives for financial statement reporting of depreciation are: Machinery and equipment 2-7 years Furniture and fixtures 3 years Leasehold improvements * (*) Amortized on a straight-line basis over the term of the lease or the estimated useful lives, whichever period is shorter.
Schedule of Expenses of Slotting Fees, Sales Discounts and Allowances are Accounted as Direct Reduction of Revenues	Expenses such as slotting fees, sales discounts, and allowances are accounted for as a direct reduction of revenues as follows: Six Months Ended July 31, 2017 Six Months Ended July 31, 2016 Gross Sales $ 12,587,604 $ 8,298,592 Less: Slotting, Discounts, Allowances 224,869 236,335 Net Sales $ 12,362,735 $ 8,062,257
Schedule of Fair Value of Share-Based Payments	For the six months ended July 31, 2017 and 2016, when computing fair value of share-based payments, the Company has considered the following variables: July 31, 2017 July 31, 2016 Risk-free interest rate 1.18 % 1.07% to 1.33 % Expected life of grants 3.76 years 2.5 to 3.5 years Expected volatility of underlying stock 298 % 166% to 179 % Dividends 0 % 0 %
Schedule of Earnings Per Share, Basic and Diluted	The following table provides a reconciliation of the numerator and denominator used in computing basic and diluted net income (loss) attributable to common stockholders per common share. For the Three Months Ended July 31, 2017 July 31, 2016 Numerator: Net loss attributable to common stockholders $ (20,366 ) $ (323,610 ) Effect of dilutive securities: — Diluted net (loss) $ (20,366 ) $ (323,610 ) Denominator: Weighted average common shares outstanding - basic 28,100,066 27,039,199 Dilutive securities (a): Series A Preferred - — Options - — Warrants - — Weighted average common shares outstanding and assumed conversion - diluted 28,100,066 27,039,199 Basic net (loss) per common share $ (0.00 ) $ (0.01 ) Diluted net (loss) per common share $ (0.00 ) $ (0.01 ) (a) - Anti-dilutive securities excluded: 7,652,372 9,189,805 For the Six Months Ended July 31, 2017 July 31, 2016 Numerator: Net income/(loss) attributable to common stockholders $ 61,059 $ (614,238 ) Effect of dilutive securities: — Diluted net (loss) $ 61,059 $ (614,238 ) Denominator: Weighted average common shares outstanding - basic 27,957,789 26,776,2798 Dilutive securities (a): Series A Preferred - — Options 254,051 — Warrants 1,587,736 — Weighted average common shares outstanding and assumed conversion - diluted 29,799,576 26,776,279 Basic net (loss) per common share $ (0.00 ) $ (0.02 ) Diluted net (loss) per common share $ (0.00 ) $ (0.02 ) (a) - Anti-dilutive securities excluded: 3,230,150 9,189,805

Property and Equipment (Tables)

Property and Equipment (Tables)	6 Months Ended
	Jul. 31, 2017
Property, Plant and Equipment [Abstract]
Schedule of Property and Equipment	Property and equipment on July 31, 2017 and January 31, 2017 are as follows: July 31, 2017 January 31, 2017 Machinery and Equipment $ 1,285,187 $ 1,193,473 Furniture and Fixtures 23,067 17,942 Leasehold Improvements 1,071,239 825,198 2,379,493 2,036,613 Less: Accumulated Depreciation 1,080,310 861,105 $ 1,299,183 $ 1,175,508

Loan and Security Agreement (Ta

Loan and Security Agreement (Tables)	6 Months Ended
	Jul. 31, 2017
Debt Disclosure [Abstract]
Schedule of Line of Credit	The facility consists of the following: ● Accounts Revolving Line of Credit: $ 2,150,000 ● Inventory Revolving Line of Credit: $ 350,000 ● Term Loan: $ 700,000

Note Payable (Tables)

Note Payable (Tables)	6 Months Ended
	Jul. 31, 2017
Debt Disclosure [Abstract]
Schedule of Monthly Principal Payment	2) The Company shall make monthly principal payments to Manatuck as follows: March 2017-September 2017 $ 100,000 October 2017-December 2017 $ 150,000 January 2018-May 1, 2018 $ 200,000
Schedule of Future Maturities of Long Term Debt	Future maturities of all debt (including debt discussed above in Notes 5, 6 and 7) are as follows: For the Twelve-Month Period Ending July 31, 2018 $ 4,720,891 2019 257,660 2020 140,004 2021 140,004 2022 23,314 $ 5,281,873

Stockholders' Equity (Tables)

Stockholders' Equity (Tables)	6 Months Ended
	Jul. 31, 2017
Equity [Abstract]
Summary of Option Activity	The following is a summary of the Company’s option activity: Options Weighted Average Exercise Price Outstanding – January 31, 2017 881,404 $ 0.78 Exercisable – January 31, 2017 799,404 $ 0.78 Granted - $ - Exercised - $ - Forfeited/Cancelled (229,404 ) $ 1.00 Outstanding – July 31, 2017 652,000 $ 0.71 Exercisable – July 31, 2017 611,000 $ 0.71
Summary of Option Outstanding and Exercisable	Options Outstanding Options Exercisable Exercise Price Number Outstanding Weighted Average Remaining Contractual Life (in years) Weighted Average Exercise Price Number Exercisable Weighted Average Exercise Price $ 0.39 – 2.97 652,000 2.51 years $ 0.71 611,000 $ 0.71
Schedule of Warrants Activity	The following is a summary of the Company’s warrant activity: Warrants Weighted Average Exercise Price Outstanding – January 31, 2017 7,311,770 $ 1.04 Exercisable – January 31, 2017 7,311,770 $ 1.04 Granted - $ - Exercised - $ - Forfeited/Cancelled (311,400 ) $ 1.00 Outstanding – July 31, 2017 7,000,372 $ 1.05 Exercisable – July 31, 2017 7,000,372 $ 1.05
Schedule of Warrants Outstanding and Exercisable	Warrants Outstanding Warrants Exercisable Range of Exercise Price Number Outstanding Weighted Average Remaining Contractual Life (in years) Weighted Average Exercise Price Number Exercisable Weighted Average Exercise Price $ 0.68-$2.50 7,000,372 3.06 years $ 1.05 7,000,372 $ 1.05

Commitments and Contingencies (

Commitments and Contingencies (Tables)	6 Months Ended
	Jul. 31, 2017
Commitments and Contingencies Disclosure [Abstract]
Schedule of Royalty Minimum Payment by Preceding Agreement Year	In order to continue the Exclusive term, the Company shall pay a minimum royalty with respect to the preceding Agreement year as follows: Agreement Year Minimum Royalty to be Paid with Respect to Such Agreement Year 1 st nd $ - 3 rd th $ 50,000 5 th th $ 75,000 8 th th $ 100,000 10 th $ 125,000
Schedule of Future Minimum Payments Under Operating Leases	Total future minimum payments required under operating lease as of July 31, 2017 are as follows: For the Twelve Months Ending July 31, 2018 $ 18,852 2019 12,568 $ 31,420

Nature of Operations and Basi25

Nature of Operations and Basis of Presentation (Details Narrative) - USD ($)	3 Months Ended		6 Months Ended
	Jul. 31, 2017	Jul. 31, 2016	Jul. 31, 2017	Jul. 31, 2016	Jan. 31, 2017	Jan. 31, 2016
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Net loss	$ 24,399	$ (276,810)	$ 152,624	$ (502,917)
Cash	639,454	$ 264,446	639,454	264,446	$ 666,580	$ 587,422
Working capital deficit	$ 67,443		67,443
Net cash generated from operating activities			$ 388,605	$ (23,403)

Summary of Significant Accoun26

Summary of Significant Accounting Policies (Details Narrative) - USD ($)	3 Months Ended		6 Months Ended
	Jul. 31, 2017	Jul. 31, 2016	Jul. 31, 2017	Jul. 31, 2016	Jan. 31, 2017
Accounting Policies [Abstract]
Cash equivalents
Accounts receivable reserves	2,000		2,000		$ 2,000
Research and development expense	24,531	$ 37,225	50,119	$ 67,787
Advertising expenses	405,349	350,665	722,943	771,557
Share-based compensation	$ 57,349	$ 172,929	$ 147,499	$ 352,137

Summary of Significant Accoun27

Summary of Significant Accounting Policies - Schedule of Inventories (Details) - USD ($)	Jul. 31, 2017	Jan. 31, 2017
Accounting Policies [Abstract]
Finished goods	$ 235,207	$ 443,623

Summary of Significant Accoun28

Summary of Significant Accounting Policies - Schedule of Property and Equipment Estimated Useful Lives (Details)	6 Months Ended
	Jul. 31, 2017
Furniture and Fixtures [Member]
Property and equipment estimated useful lives	3 years
Leasehold Improvements [Member]
Property and equipment estimated useful lives	0 years	[1]
Minimum [Member] | Machinery and Equipment [Member]
Property and equipment estimated useful lives	2 years
Maximum [Member] | Machinery and Equipment [Member]
Property and equipment estimated useful lives	7 years
[1]	Amortized on a straight-line basis over the term of the lease or the estimated useful lives, whichever period is shorter.

Summary of Significant Accoun29

Summary of Significant Accounting Policies - Schedule of Expenses of Slotting Fees, Sales Discounts and Allowances are Accounted as Direct Reduction of Revenues (Details) - USD ($)	3 Months Ended		6 Months Ended
	Jul. 31, 2017	Jul. 31, 2016	Jul. 31, 2017	Jul. 31, 2016
Accounting Policies [Abstract]
Gross Sales			$ 12,587,604	$ 8,298,592
Less: Slotting, Discounts, Allowances			224,869	236,335
Net Sales	$ 7,005,434	$ 4,138,280	$ 12,362,735	$ 8,062,257

Summary of Significant Accoun30

Summary of Significant Accounting Policies - Schedule of Fair Value of Share-Based Payments (Details)	6 Months Ended
	Jul. 31, 2017	Jul. 31, 2016
Risk-free interest rate	1.18%
Risk-free interest rate, minimum		1.07%
Risk-free interest rate, maximum		1.33%
Expected life of grants	3 years 9 months 3 days
Expected volatility of underlying stock, minimum		166.00%
Expected volatility of underlying stock, maximum		179.00%
Expected volatility of underlying stock	298.00%
Dividends	0.00%	0.00%
Maximum [Member]
Expected life of grants		2 years 6 months
Minimum [Member]
Expected life of grants		3 years 6 months

Summary of Significant Accoun31

Summary of Significant Accounting Policies - Schedule of Earnings Per Share, Basic and Diluted (Details) - USD ($)	3 Months Ended		6 Months Ended
	Jul. 31, 2017	Jul. 31, 2016	Jul. 31, 2017	Jul. 31, 2016
Accounting Policies [Abstract]
Net income/(loss) attributable to common stockholders	$ (20,366)	$ (323,610)	$ 61,059	$ (614,238)
Effect of dilutive securities
Diluted net (loss)	$ (20,366)	$ (323,610)	$ 61,059	$ (614,238)
Weighted average common shares outstanding - basic	28,100,066	27,039,199	27,957,789	26,776,279
Series A Preferred
Options			254,051
Warrants			1,587,736
Weighted average common shares outstanding and assumed conversion - diluted	28,100,066	27,039,199	29,799,576	26,776,279
Basic net (loss) per common share	$ 0	$ (0.01)	$ 0	$ (0.02)
Diluted net (loss) per common share	$ 0	$ (0.01)	$ 0	$ (0.02)
(a) - Anti-dilutive securities excluded	7,652,372	9,189,805	3,230,150	9,189,805

Property and Equipment (Details

Property and Equipment (Details Narrative) - USD ($)	3 Months Ended		6 Months Ended
	Jul. 31, 2017	Jul. 31, 2016	Jul. 31, 2017	Jul. 31, 2016
Property, Plant and Equipment [Abstract]
Depreciation expense	$ 112,124	$ 83,000	$ 219,205	$ 137,585

Property and Equipment - Schedu

Property and Equipment - Schedule of Property and Equipment (Details) - USD ($)	Jul. 31, 2017	Jan. 31, 2017
Property, Plant and Equipment [Abstract]
Machinery and Equipment	$ 1,285,187	$ 1,193,473
Furniture and Fixtures	23,067	17,942
Leasehold Improvements	1,071,239	825,198
Property plant and equipment, gross	2,379,493	2,036,613
Less: Accumulated Depreciation	1,080,310	861,105
Property, plant and equipment, net	$ 1,299,183	$ 1,175,508

Investment in Meatball Obsess34

Investment in Meatball Obsession, LLC (Details Narrative) - Meatball Obsession, LLC [Member] - USD ($)	Dec. 31, 2011	Jul. 31, 2017	Jan. 31, 2017
Percentage of equity interest acquired in business combination	34.62%
Investment in business combination	$ 27,032
Reduction in investment due to losses in affiliates	$ 0
Ownership interest percentage		12.00%	12.00%

Related Party Transactions (Det

Related Party Transactions (Details Narrative) - USD ($)	Oct. 29, 2015	Mar. 01, 2010	Aug. 31, 2016	Jul. 31, 2017	Jul. 31, 2016	Jul. 31, 2017	Jul. 31, 2016	Jan. 31, 2016	Jan. 31, 2017
Voting rights description		For purposes of the agreement, a Change of Control shall occur when a third party who is not currently a shareholder of the Company acquires control of at least fifty-one percent (51%) of the voting shares of the Company.
Purchased inventory from manufacturer				$ 5,062,421	$ 2,667,959	$ 8,369,528	$ 5,368,970
Administrative expenses and salary expenses				15,000	6,000	30,000	12,000
Due from manufacturer - related party				1,597,518		1,597,518			$ 2,079,708
Proceeds from notes payable with related party							650,000
Debt maturity date	Dec. 19, 2016		Sep. 30, 2017
Note principal balance amount				117,656		117,656			117,656
Meatball Obsession, LLC [Member]
Revenue from related parties				10,468	223	33,039	10,325
Due from related party				5,261		5,261			$ 8,189
WWS, Inc [Member]
Commission expense				$ 12,000	$ 12,000	24,000	$ 24,000
CEO [Member]
Proceeds from notes payable with related party								$ 125,000
Note bears interest rate per annum								4.00%
Debt maturity date								Dec. 31, 2016
CEO [Member] | Extended Maturity [Member]
Debt maturity date								Feb. 28, 2019
Joseph Epstein Foods [Member]
Minimum purchase of product each month amount						$ 965,000
Percentage of shortfall each month						12.00%
Percentage of overage of gross margin each month						12.00%

Loan and Security Agreement (De

Loan and Security Agreement (Details Narrative) - USD ($)	Oct. 29, 2015	Sep. 03, 2014	Jul. 31, 2017	Sep. 30, 2016	Aug. 31, 2016	Jul. 31, 2017	Jul. 31, 2016	Jan. 31, 2017	Jul. 01, 2017
Line of credit			$ 2,454,151			$ 2,454,151		$ 1,363,145
Debt instrument face amount					$ 2,898,523
Repayments of debt						70,002	$ 60,000
Debt instrument, increase	$ 220,000
Extended maturity date	Dec. 19, 2016				Sep. 30, 2017
Repayment of secured debt, monthly installment basis						2,126,736		2,700,725
Loan and Security Agreement [Member] | Entrepreneur Growth Capital LLC [Member]
Line of credit aggregate value				$ 3,200,000
Percentage of accounts revolving line of credit maximum				85.00%
Percentage of finished goods amount				50.00%
Percentage of raw material amount				20.00%
Raw material capped				$ 30,000
Line of credit interest rate description				The revolving interest rates is equal to the highest prime rate in effect during each month as generally reported by Citibank, N.A. plus (a) 2.5% on loans and advances made against eligible accounts and (b) 4.0% on loans made against eligible inventory. The term loan bears interest at a rate of the highest prime rate in effect during each month as generally reported by Citibank, N.A. plus 4.0%. The initial term of the facility is for a period of two years and will automatically renew for an additional one -year period. The Company is required to pay an annual facility fee equal to 0.75% of the total $3,200,000 facility and pays an annualized maintenance fee equal to 2.16% of the total facility. In the event of default, the Company shall pay 10% above the stated rates of interest per the Agreement. The drawdowns are secured by all of the assets of the Company.
Line of credit facility annualized maintenance fee				$ 3,200,000
Line of credit annual facility percentage				0.75%
Line of credit fee percentage				2.16%
Line of credit default stated rates of interest				10.00%
Entrepreneur Growth Capital, LLC [Member]
Debt instrument face amount									$ 3,000,000
Repayments of debt			50,000
Entrepreneur Growth Capital LLC [Member] | Secured Promissory Note [Member]
Line of credit aggregate value		$ 600,000
Line of credit interest rate description		The EGC Note bears interest at the prime rate plus 4.0% and is payable monthly, in arrears. In the event of default, the Company shall pay 10% above the stated rates of interest per the Loan and Security Agreement.
Line of credit default stated rates of interest		10.00%
Term of loan		5 years
Debt instrument, increase				$ 700,000
Extended maturity date				Sep. 30, 2021
Repayment of secured debt, monthly installment basis		$ 11,667
Term loan outstanding			583,330			583,330		$ 653,332
Maximum [Member]
Line of credit			2,500,000			2,500,000
Line of credit aggregate value			$ 3,200,000			$ 3,200,000

Loan and Security Agreement - S

Loan and Security Agreement - Schedule of Line of Credit (Details)	Sep. 03, 2014USD ($)
Accounts Revolving Line of Credit [Member]
Line of credit facility	$ 2,150,000
Inventory Revolving Line of Credit [Member]
Line of credit facility	350,000
Term Loan [Member]
Line of credit facility	$ 700,000

Note Payable (Details Narrative

Note Payable (Details Narrative) - USD ($)	Mar. 31, 2017	Oct. 31, 2016	Oct. 29, 2015	Dec. 19, 2014	Aug. 31, 2016	Jul. 31, 2017	Jul. 31, 2016	Jul. 31, 2017	Jul. 31, 2016	Jan. 31, 2017
Common stock price per shares						$ 0.675		$ 0.675
Debt discount						$ 8,730	$ 9,694	$ 26,010	$ 18,819
Debt maturity date			Dec. 19, 2016		Sep. 30, 2017
Sale of stock during period			230,000
Sale of stock price per share			$ 0.65
Sale of stock during period, value			$ 149,500
Amendment fee			170,500					170,500
Accrued interest			220,000
Increased in outstanding principal of debt			220,000
Debt extinguishment			2,000,000
Unamortized debt discount			190,483			190,483		190,483
Debt issuance cost			19,106			19,106		19,106
Loss on debt extinguishment			380,089
Remaining debt discount			$ 190,483
Outstanding principal debt					$ 2,898,523
Origination fees		$ 50,000
Accrued fee percentage	2.00%
Debt fee	$ 52,236
Unamortized debt discount, net						$ 74,320		74,320		$ 48,094
Debt instrument, periodic payment								$ 2,126,736		$ 2,700,725
Manatuck Purchase Agreement [Member]
Debt maturity month year								May 1, 2018
Debt instrument, description								The Company will pay to Manatuck a cash fee equal to two percent (2%) of the mutually-agreed pro-forma balance payable on account of the note as of March 31, 2017, which shall include all interest which would be accrued on the note through March 31, 2017
Manatuck Purchase Agreement [Member] | Manatuck Hill Partners, LLC [Member]
Convertible debenture				$ 2,000,000
Convertible debt, interest rate percentage				14.00%
Debt maturity month year				February 2,016
Number of restricted common stock granted, shares				200,000				30,000
Debt maturity extended month year								May 2,016
Common stock price per shares						$ 1.32		$ 1.32
Debt discount				$ 498,350				$ 39,600

Note Payable - Schedule of Mont

Note Payable - Schedule of Monthly Principal Payment (Details) - USD ($)	Jul. 31, 2017	Aug. 31, 2016
Monthly principal payments		$ 2,898,523
Manatuck Purchase Agreement [Member] | March 2017-September 2017 [Member]
Monthly principal payments	$ 100,000
Manatuck Purchase Agreement [Member] | March 2017-December 2017 [Member]
Monthly principal payments	150,000
Manatuck Purchase Agreement [Member] | January 2018-May 1, 2018 [Member]
Monthly principal payments	$ 200,000

Note Payable - Schedule of Futu

Note Payable - Schedule of Future Maturities of Long Term Debt (Details)	Jul. 31, 2017USD ($)
Debt Disclosure [Abstract]
2,018	$ 4,720,891
2,019	257,660
2,020	140,004
2,021	140,004
2,022	23,314
Future maturities of long term debt total	$ 5,281,873

Concentrations (Details Narrati

Concentrations (Details Narrative)	6 Months Ended
	Jul. 31, 2017	Jul. 31, 2016
Sales Revenue [Member] | Customer A [Member]
Concentrations of risk percentage	39.00%	20.00%
Sales Revenue [Member] | Customer B [Member]
Concentrations of risk percentage	11.00%	13.00%
Sales Revenue [Member] | Customer C [Member]
Concentrations of risk percentage	10.00%	12.00%
Sales Revenue [Member] | Customer D [Member]
Concentrations of risk percentage		11.00%
Accounts Receivable [Member] | Customer A [Member]
Concentrations of risk percentage	43.00%	19.00%
Accounts Receivable [Member] | Customer B [Member]
Concentrations of risk percentage	11.00%	17.00%
Accounts Receivable [Member] | Customer C [Member]
Concentrations of risk percentage	19.00%	12.00%
Cost Of Sales [Member] | Vendor One [Member]
Concentrations of risk percentage	100.00%	100.00%

Stockholders' Equity (Details N

Stockholders' Equity (Details Narrative) - USD ($)	Jul. 27, 2017	Oct. 29, 2015	Jul. 31, 2017	Jul. 31, 2016
Number of preferred stock converted into common stock	3,466,667
Series A Preferred dividend issued in common shares, shares			90,717
Series A Preferred dividend issued in common shares			$ 91,565
Number of stock issued for employees services			138,500
Repurchase of treasury stock, shares		230,000
Repurchase of treasury stock		$ 149,500		$ (149,500)
Total intrinsic value of options outstanding			323,560
Total intrinsic value of options exercisable			299,780
Recognized stock options			8,999	$ 112,304
Unrecognized stock based compensation			23,405
Warrant [Member]
Total intrinsic value of options exercisable			1,873,529
Total intrinsic value of warrants outstanding			$ 1,873,529
Employees [Member]
Number of stock issued for employees services , shares			135,564
Number of stock issued for employees services			$ 138,500
Series A Preferred Stockholders [Member]
Number of preferred stock converted into common stock	23,400
Common stock price trigger volume weighted average price per share	$ 1.0125

Stockholders' Equity - Summary

Stockholders' Equity - Summary of Option Activity (Details)	6 Months Ended
	Jul. 31, 2017$ / sharesshares
Equity [Abstract]
Options Outstanding, Beginning balance | shares	881,404
Options Exercisable, Beginning balance | shares	799,404
Options, Granted | shares
Options, Exercised | shares
Options, Forfeited/Cancelled | shares	(229,404)
Options Outstanding, Ending balance | shares	652,000
Options Exercisable, Ending balance | shares	611,000
Options Outstanding, Weighted Average Exercise Price, Beginning balance | $ / shares	$ 0.78
Options Exercisable, Weighted Average Exercise Price, Beginning balance | $ / shares	0.78
Weighted Average Exercise Price, Granted | $ / shares
Weighted Average Exercise Price, Exercised | $ / shares
Weighted Average Exercise Price, Forfeited/Cancelled | $ / shares	1
Options Outstanding, Weighted Average Exercise Price, Ending balance | $ / shares	0.71
Options Exercisable, Weighted Average Exercise Price, Ending balance | $ / shares	$ 0.71

Stockholders' Equity - Summar44

Stockholders' Equity - Summary of Option Outstanding and Exercisable (Details) - Range Of Exercise Price One [Member]	6 Months Ended
	Jul. 31, 2017$ / sharesshares
Range of exercise price lower range limit	$ 0.39
Range of exercise price upper range limit	$ 2.97
Number of Options Outstanding | shares	652,000
Weighted Average Remaining Contractual Life (in years), Options Outstanding	2 years 6 months 3 days
Weighted Average Exercise Price, Options Outstanding	$ 0.71
Number of Options Exercisable | shares	611,000
Weighted Average Exercise Price, Options Exercisable	$ 0.71

Stockholders' Equity - Schedule

Stockholders' Equity - Schedule of Warrants Activity (Details) - Warrant [Member]	6 Months Ended
	Jul. 31, 2017$ / sharesshares
Warrants Outstanding, Beginning balance | shares	7,311,770
Warrants Exercisable, Beginning balance | shares	7,311,770
Warrants, Granted | shares
Warrants, Exercised | shares
Warrants, Forfeited/Cancelled | shares	(311,400)
Warrants Outstanding, Ending balance | shares	7,000,372
Warrants Exercisable, Ending balance | shares	7,000,372
Warrants Outstanding, Weighted Average Exercise Price, Beginning balance | $ / shares	$ 1.04
Warrants Exercisable, Weighted Average Exercise Price, Beginning balance | $ / shares	1.04
Weighted Average Exercise Price, Granted | $ / shares
Weighted Average Exercise Price, Exercised | $ / shares
Weighted Average Exercise Price, Forfeited/Cancelled | $ / shares	1
Warrants Outstanding, Weighted Average Exercise Price, Ending balance | $ / shares	1.05
Warrants Exercisable, Weighted Average Exercise Price, Ending balance | $ / shares	$ 1.05

Stockholders' Equity - Schedu46

Stockholders' Equity - Schedule of Warrants Outstanding and Exercisable (Details) - Warrant [Member] - $ / shares	6 Months Ended
	Jul. 31, 2017	Jan. 31, 2017
Range of Exercise Price, lower limit	$ 0.68
Range of Exercise Price, upper limit	$ 2.50
Number of Warrants Outstanding	7,000,372	7,311,770
Weighted Average Remaining Contractual Life (in Years)	3 years 22 days
Weighted Average Exercise Price, Warrants Outstanding	$ 1.05
Number of Warrants Exercisable	7,000,372	7,311,770
Weighted Average Exercise Price, Warrants Exercisable	$ 1.05	$ 1.04

Commitments and Contingencies47

Commitments and Contingencies (Details Narrative) - USD ($)	1 Months Ended	3 Months Ended		6 Months Ended		12 Months Ended
	Jan. 31, 2015	Jul. 31, 2017	Jul. 31, 2016	Jul. 31, 2017	Jul. 31, 2016	Jan. 31, 2016
Royalty expenses		$ 89,244	$ 55,980	$ 206,191	$ 141,684
Warrants issued to investors		179,259		179,259
Shares issued exercise price per share		$ 0.675		$ 0.675
Warrants grant date fair value				$ 84,547
Operating lease annual payments		$ 31,420		$ 31,420
Spartan Capital Securities, LLC [Member]
Percentage of fee equal to aggregate gross proceeds				10.00%
Percentage of fees equal to aggregate gross proceeds for expenses				3.00%
Percentage of common stock issuable				10.00%
One-time engagement fee						$ 10,000
Cash fee and non-accountable allowance						$ 157,300
Spartan Capital Securities, LLC [Member] | Advisory Agreement [Member]
Nonrefundable monthly fee amount				$ 10,000
Operating lease expiration term	51 months
Lease agreement expire date	Mar. 31, 2019
Operating lease annual payments	$ 18,847
Minimum [Member] | Spartan Capital Securities, LLC [Member] | Advisory Agreement [Member]
Nonrefundable monthly fee amount				$ 5,000
Nonrefundable monthly fee term				November 1, 2015 through October 2017
Aggregate gross proceeds fee				$ 4,000,000
Maximum [Member] | Spartan Capital Securities, LLC [Member] | Advisory Agreement [Member]
Nonrefundable monthly fee amount				$ 5,000
Nonrefundable monthly fee term				November 1, 2017 through October 2019
Aggregate gross proceeds fee				$ 5,000,000
Year 1 [Member]
Percentage of royalty on net sales				6.00%
Royalty revenue				$ 500,000
Year 2 [Member]
Percentage of royalty on net sales				4.00%
Year 2 [Member] | Minimum [Member]
Royalty revenue				$ 500,000
Year 2 [Member] | Maximum [Member]
Royalty revenue				$ 2,500,000
Year 3 [Member]
Percentage of royalty on net sales				2.00%
Year 3 [Member] | Minimum [Member]
Royalty revenue				$ 2,500,000
Year 3 [Member] | Maximum [Member]
Royalty revenue				$ 20,000,000
Year 4 [Member]
Percentage of royalty on net sales				1.00%
Royalty revenue				$ 20,000,000
$10,000,000 or More Raised Financing [Member] | Spartan Capital Securities, LLC [Member] | Advisory Agreement [Member]
Nonrefundable monthly fee amount				$ 5,000
Nonrefundable monthly fee term				November 1, 2015 through October 1, 2019
Aggregate gross proceeds fee				$ 10,000,000

Commitments and Contingencies -

Commitments and Contingencies - Schedule of Royalty Minimum Payment by Preceding Agreement Year (Details) - USD ($)	3 Months Ended		6 Months Ended
	Jul. 31, 2017	Jul. 31, 2016	Jul. 31, 2017	Jul. 31, 2016
Minimum Royalty to be Paid	$ 89,244	$ 55,980	$ 206,191	$ 141,684
Agreement Year 1st and 2nd [Member]
Minimum Royalty to be Paid
Agreement Year 3rd and 4th [Member]
Minimum Royalty to be Paid			50,000
Agreement Year 5th, 6th and 7th [Member]
Minimum Royalty to be Paid			75,000
Agreement Year 8th and 9th [Member]
Minimum Royalty to be Paid			100,000
Agreement Year 10th and thereafter [Member]
Minimum Royalty to be Paid			$ 125,000

Commitments and Contingencies49

Commitments and Contingencies - Schedule of Future Minimum Payments Under Operating Leases (Details)	Jul. 31, 2017USD ($)
Commitments and Contingencies Disclosure [Abstract]
2,018	$ 18,852
2,019	12,568
Total	$ 31,420

Subsequent Events (Details Narr

Subsequent Events (Details Narrative) - USD ($)	Oct. 29, 2015	Jul. 31, 2017
Extinguishment of loan between the parties	$ 2,000,000
Subsequent Event [Member] | Joseph Epstein Food Enterprises, Inc [Member]
Payment to acquire assets		$ 2,928,825
Accounts payable and accrued expenses		2,656,948
Third-party loans		782,000
Collateralization of a bank loan amount		250,000
Subsequent Event [Member] | Inter-Company [Member] | Parties [Member]
Extinguishment of loan between the parties		$ 1,597,518